Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 58 | $12,351,444 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
19 Jan 2023 16:03 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 17 Jan 2023 | Sale | 1,034 | 29.49 | 30,493 | D |
19 Jan 2023 16:03 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 17 Jan 2023 | Sale | 18,966 | 28.82 | 546,600 | D |
01 Feb 2023 16:04 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 30 Jan 2023 | Sale | 3,300 | 29.88 | 98,604 | D |
01 Feb 2023 16:04 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 30 Jan 2023 | Sale | 16,700 | 29.22 | 487,974 | D |
15 Feb 2023 16:03 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 13 Feb 2023 | Sale | 20,000 | 28.62 | 572,400 | D |
16 Feb 2023 16:04 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 14 Feb 2023 | Sale | 504 | 28.59 | 14,409 | D |
21 Feb 2023 16:05 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 16 Feb 2023 | Sale | 233 | 27.21 | 6,340 | D |
01 Mar 2023 16:06 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 27 Feb 2023 | Sale | 20,000 | 25.37 | 507,400 | D |
07 Mar 2023 16:02 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 03 Mar 2023 | Sale | 504 | 24.29 | 12,242 | D |
15 Mar 2023 17:11 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 13 Mar 2023 | Sale | 1,667 | 22.72 | 37,874 | D |
15 Mar 2023 17:11 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 13 Mar 2023 | Sale | 18,333 | 22.47 | 411,943 | D |
29 Mar 2023 21:30 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 27 Mar 2023 | Sale | 20,000 | 22.15 | 443,000 | D |
05 Apr 2023 16:03 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 03 Apr 2023 | Sale | 16,363 | 22.85 | 373,895 | D |
30 Jun 2023 16:02 | AGIO | AGIOS PHARMACEUTICALS Inc | MILANOVA TSVETA | Chief Commercial Officer | 30 Jun 2023 | Sale | 1,618 | 28.36 | 45,886 | D |
30 Jun 2023 16:03 | AGIO | AGIOS PHARMACEUTICALS Inc | JONES CECILIA | Chief Financial Officer | 30 Jun 2023 | Sale | 1,597 | 28.36 | 45,291 | D |
30 Jun 2023 16:05 | AGIO | AGIOS PHARMACEUTICALS Inc | GOFF BRIAN | Chief Executive Officer | 30 Jun 2023 | Sale | 11,449 | 28.36 | 324,694 | D |
30 Jun 2023 16:06 | AGIO | AGIOS PHARMACEUTICALS Inc | GHEUENS SARAH | Chief Medical Officer | 30 Jun 2023 | Sale | 1,707 | 28.36 | 48,411 | D |
30 Jun 2023 16:07 | AGIO | AGIOS PHARMACEUTICALS Inc | FOUSE JACQUALYN A | Director | 30 Jun 2023 | Sale | 10,718 | 28.36 | 303,962 | D |
30 Jun 2023 16:09 | AGIO | AGIOS PHARMACEUTICALS Inc | BURNS JAMES WILLIAM | Chief Legal Officer | 30 Jun 2023 | Sale | 1,707 | 28.36 | 48,411 | D |
02 Aug 2023 16:02 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 01 Aug 2023 | Sale | 1,232 | 26.26 | 32,352 | D |
09 Aug 2023 16:04 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 07 Aug 2023 | Sale | 2,918 | 25.3927 | 74,096 | D |
10 Aug 2023 16:07 | AGIO | AGIOS PHARMACEUTICALS Inc | GOFF BRIAN | Chief Executive Officer | 08 Aug 2023 | Sale | 10,178 | 25.48 | 259,335 | D |
11 Aug 2023 16:04 | AGIO | AGIOS PHARMACEUTICALS Inc | FOSTER-CHEEK KAYE I | Director | 09 Aug 2023 | Sale | 25,000 | 25.9555 | 648,888 | D |
21 Aug 2023 16:03 | AGIO | AGIOS PHARMACEUTICALS Inc | BURNS JAMES WILLIAM | Chief Legal Officer | 17 Aug 2023 | Sale | 6,395 | 26.28 | 168,061 | D |
28 Sep 2023 16:02 | AGIO | AGIOS PHARMACEUTICALS Inc | JONES CECILIA | Chief Financial Officer | 28 Sep 2023 | Sale | 2,179 | 24.79 | 54,017 | D |
05 Jan 2024 16:10 | AGIO | AGIOS PHARMACEUTICALS Inc | MILANOVA TSVETA | Chief Commercial Officer | 05 Jan 2024 | Sale | 2,902 | 22.32 | 64,773 | D |
09 Jan 2024 16:22 | AGIO | AGIOS PHARMACEUTICALS Inc | GHEUENS SARAH | Chief Medical Officer | 09 Jan 2024 | Sale | 1,789 | 22.99 | 41,129 | D |
09 Jan 2024 16:25 | AGIO | AGIOS PHARMACEUTICALS Inc | BURNS JAMES WILLIAM | Chief Legal Officer | 09 Jan 2024 | Sale | 1,163 | 22.99 | 26,737 | D |
09 Jan 2024 16:26 | AGIO | AGIOS PHARMACEUTICALS Inc | FOUSE JACQUALYN A | Director | 09 Jan 2024 | Sale | 8,391 | 22.99 | 192,909 | D |
09 Jan 2024 16:28 | AGIO | AGIOS PHARMACEUTICALS Inc | GOFF BRIAN | Chief Executive Officer | 09 Jan 2024 | Sale | 12,066 | 22.99 | 277,397 | D |
24 Jan 2024 16:19 | AGIO | AGIOS PHARMACEUTICALS Inc | MILANOVA TSVETA | Chief Commercial Officer | 24 Jan 2024 | Sale | 1,618 | 21.64 | 35,014 | D |
24 Jan 2024 16:20 | AGIO | AGIOS PHARMACEUTICALS Inc | GOFF BRIAN | Chief Executive Officer | 24 Jan 2024 | Sale | 7,635 | 21.64 | 165,221 | D |
24 Jan 2024 16:22 | AGIO | AGIOS PHARMACEUTICALS Inc | FOUSE JACQUALYN A | Director | 24 Jan 2024 | Sale | 10,722 | 21.64 | 232,024 | D |
24 Jan 2024 16:23 | AGIO | AGIOS PHARMACEUTICALS Inc | JONES CECILIA | Chief Financial Officer | 24 Jan 2024 | Sale | 1,886 | 21.64 | 40,813 | D |
24 Jan 2024 16:24 | AGIO | AGIOS PHARMACEUTICALS Inc | GHEUENS SARAH | Chief Medical Officer | 24 Jan 2024 | Sale | 1,708 | 21.64 | 36,961 | D |
24 Jan 2024 16:25 | AGIO | AGIOS PHARMACEUTICALS Inc | BURNS JAMES WILLIAM | Chief Legal Officer | 24 Jan 2024 | Sale | 1,708 | 21.64 | 36,961 | D |
14 Feb 2024 17:50 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 14 Feb 2024 | Sale | 273 | 25.14 | 6,863 | D |
14 Feb 2024 17:51 | AGIO | AGIOS PHARMACEUTICALS Inc | BURNS JAMES WILLIAM | Chief Legal Officer | 14 Feb 2024 | Sale | 545 | 25.14 | 13,701 | D |
14 Feb 2024 17:53 | AGIO | AGIOS PHARMACEUTICALS Inc | GHEUENS SARAH | Chief Medical Officer | 14 Feb 2024 | Sale | 642 | 25.14 | 16,140 | D |
22 Feb 2024 17:43 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 20 Feb 2024 | Sale | 504 | 26.63 | 13,422 | D |
27 Feb 2024 16:04 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 26 Feb 2024 | Sale | 20,411 | 33.19 | 677,441 | D |
27 Feb 2024 16:04 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 23 Feb 2024 | Sale | 47,731 | 33.05 | 1,577,510 | D |
29 Feb 2024 16:05 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 27 Feb 2024 | Sale | 57,471 | 34.89 | 2,005,163 | D |
29 Feb 2024 16:05 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 27 Feb 2024 | Sale | 11,858 | 33.6 | 398,429 | D |
05 Mar 2024 16:08 | AGIO | AGIOS PHARMACEUTICALS Inc | BURNS JAMES WILLIAM | Chief Legal Officer | 05 Mar 2024 | Sale | 1,349 | 32.57 | 43,937 | D |
05 Mar 2024 16:08 | AGIO | AGIOS PHARMACEUTICALS Inc | BURNS JAMES WILLIAM | Chief Legal Officer | 05 Mar 2024 | Sale | 1,293 | 32.57 | 42,113 | D |
05 Mar 2024 16:10 | AGIO | AGIOS PHARMACEUTICALS Inc | GOFF BRIAN | Chief Executive Officer | 05 Mar 2024 | Sale | 4,156 | 32.57 | 135,361 | D |
05 Mar 2024 16:15 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 05 Mar 2024 | Sale | 919 | 32.57 | 29,932 | D |
05 Mar 2024 16:15 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 05 Mar 2024 | Sale | 295 | 32.57 | 9,608 | D |
05 Mar 2024 16:18 | AGIO | AGIOS PHARMACEUTICALS Inc | JONES CECILIA | Chief Financial Officer | 05 Mar 2024 | Sale | 672 | 32.57 | 21,887 | D |
05 Mar 2024 16:20 | AGIO | AGIOS PHARMACEUTICALS Inc | GHEUENS SARAH | Chief Medical Officer | 05 Mar 2024 | Sale | 1,349 | 32.57 | 43,937 | D |
05 Mar 2024 16:20 | AGIO | AGIOS PHARMACEUTICALS Inc | GHEUENS SARAH | Chief Medical Officer | 05 Mar 2024 | Sale | 1,293 | 32.57 | 42,113 | D |
07 Mar 2024 18:47 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 05 Mar 2024 | Sale | 1,913 | 31.75 | 60,738 | D |
07 Mar 2024 18:49 | AGIO | AGIOS PHARMACEUTICALS Inc | FOSTER-CHEEK KAYE I | Director | 05 Mar 2024 | Sale | 300 | 32.21 | 9,663 | D |
07 Mar 2024 18:49 | AGIO | AGIOS PHARMACEUTICALS Inc | FOSTER-CHEEK KAYE I | Director | 06 Mar 2024 | Sale | 4,415 | 31.99 | 141,236 | D |
11 Mar 2024 16:09 | AGIO | AGIOS PHARMACEUTICALS Inc | FOSTER-CHEEK KAYE I | Director | 07 Mar 2024 | Sale | 1,285 | 31.62 | 40,632 | D |
10 Apr 2024 16:03 | AGIO | AGIOS PHARMACEUTICALS Inc | FOUSE JACQUALYN A | Director | 10 Apr 2024 | Sale | 7,791 | 27.55 | 214,642 | D |
05 Jun 2024 16:14 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 03 Jun 2024 | Sale | 1,362 | 44.39 | 60,459 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)